Skip to content

App for Acne inversa

App for Acne inversa - AppAi

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036247
Enrollment
60
Registered
2025-02-25
Start date
2025-05-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L73.2

Interventions

Group 1: The study will include male or female patients of legal age with acne inversa/ hidradenitis suppurativa with all degrees of severity. Prior to inclusion in the study, the underlying disease i

Sponsors

Hautklinik und Poliklinik der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Stage of severity: Hurley I-III 2. Smartphone or tablet with app download option 3. Patient is documented in the LENCURA software as part of his/her routine care

Exclusion criteria

Exclusion criteria: Insufficient knowledge of the German language

Design outcomes

Primary

MeasureTime frame
Absolute change in Hospital Anxiety and Depression Scale (HADS) after 3 months

Secondary

MeasureTime frame
- Absolute change in Health Education Impact Questionnaire (heiQ) - Absolute change in Pain-NRS - Absolute change in Dermatologischer Lebensqualitäts-Index (DLQI) - Absolute change in Insomnia Severity Index (ISI) - Absolute change in Patient reported disease activity (PRDA) Participants should also answer questions on usability.

Countries

Germany

Contacts

Public ContactMichael Schultheis

Hautklinik und Poliklinik der Universitätsmedizin der Johannes Gutenberg-Universität Mainz

michael.schultheis@unimedizin-Mainz.de+496131175732

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026